HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy and safety of cefovecin for the treatment of urinary tract infections in cats.

AbstractOBJECTIVES:
To determine the efficacy and safety of cefovecin (Convenia); Pfizer Animal Health) in the treatment of urinary tract infections in cats.
METHOD:
A multi-centre, masked, randomised study was conducted in cats presenting with clinical signs indicative of urinary tract infections. Cephalexin (Rilexine); Virbac) administered orally twice daily at 15 mg/kg bodyweight for 14 days was compared with a single subcutaneous injection of cefovecin in cats. The primary efficacy parameter assessed was bacterial elimination of the pretreatment uropathogen.
RESULTS:
Four hundred and thirty-four cats were screened for urinary tract infections. One hundred and eighty-five cats were treated with either cefovecin (n=124) or cephalexin (n=61). Ninety-seven cats (22.2 per cent) had confirmed bacteriuria and 82 cats were included in efficacy analysis. Escherichia coli was eliminated in 76.7 per cent (23 of 30) of cefovecin-treated cats compared with 62.5 per cent (10 of 16) of cephalexin-treated cats. Cefovecin demonstrated statistical non-inferiority compared with cephalexin for bacterial elimination. There were no suspected adverse drug reactions attributable to treatment with cefovecin or cephalexin.
CLINICAL SIGNIFICANCE:
Cefovecin was demonstrated to be an effective and safe treatment for urinary tract infections.
AuthorsC A Passmore, J Sherington, M R Stegemann
JournalThe Journal of small animal practice (J Small Anim Pract) Vol. 49 Issue 6 Pg. 295-301 (Jun 2008) ISSN: 0022-4510 [Print] England
PMID18422501 (Publication Type: Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Bacterial Agents
  • Cephalosporins
  • cefovecin
Topics
  • Administration, Oral
  • Animals
  • Anti-Bacterial Agents (therapeutic use)
  • Cat Diseases (drug therapy)
  • Cats
  • Cephalosporins (therapeutic use)
  • Double-Blind Method
  • Escherichia coli Infections (drug therapy, veterinary)
  • Female
  • Injections, Subcutaneous (veterinary)
  • Male
  • Safety
  • Treatment Outcome
  • Urinary Tract Infections (drug therapy, veterinary)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: